Lambertus C Dorssers

Title: The Innovations of Lambertus C Dorssers

Introduction

Lambertus C Dorssers is a notable inventor based in Randwijk, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of human interleukin-3. With a total of 2 patents, his work has implications for pharmaceutical compositions and therapeutic applications.

Latest Patents

Dorssers' latest patents include innovations related to N- and C-terminal truncation and deletion mutants of human interleukin-3. These biologically active deletion and substitution mutants are designed to enhance the efficacy of hIL-3. Preferred mutants feature deletions at the N-terminus and/or the C-terminus, with specific substitutions that can be utilized in pharmaceutical formulations. Additionally, he has developed methods for the expression and purification of human interleukin-3, improving production in both glycosylated and unglycosylated forms.

Career Highlights

Throughout his career, Dorssers has worked with prominent companies such as Gist-Brocades N.V. and DSM N.V. His expertise in biotechnology has allowed him to contribute to advancements in the production and application of interleukin-3.

Collaborations

Dorssers has collaborated with notable colleagues, including Robert W Van Leen and Gerard Wagemaker. Their combined efforts have furthered research in the field of interleukin-3 and its therapeutic potential.

Conclusion

Lambertus C Dorssers is a distinguished inventor whose work in biotechnology has led to significant advancements in the understanding and application of human interleukin-3. His contributions continue to influence the development of pharmaceutical compositions and therapeutic strategies.